| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Calcium Oscillation Project, ICORP, Japan Science and Technology Agency, Minato-ku, Tokyo 108-0071, JapanDivisions of 2 Neuronal Network3 Molecular Neurobiology, Department of Basic Medical Sciences, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan4 Laboratory of Biomedical Genetics, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan5 Department of Pharmacology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan
The M1 and M3 subtypes are the major muscarinic acetylcholine receptors in the salivary gland and M3 is reported to be more abundant. However, despite initial reports of salivation abnormalities in M3-knockout (M3KO) mice, it is still unclear which subtype is functionally relevant in physiological salivation. In the present study, salivary secretory function was examined using mice lacking specific subtype(s) of muscarinic receptor. The carbachol-induced [Ca2+]i increase was markedly impaired in submandibular gland cells from M3KO mice and completely absent in those from M1/M3KO mice. This demonstrates that M3 and M1 play major and minor roles, respectively, in the cholinergically induced [Ca2+]i increase. Two-dimensional Ca2+-imaging analysis revealed the patchy distribution of M1 in submandibular gland acini, in contrast to the ubiquitous distribution of M3. In vivo administration of a high dose of pilocarpine (10 mg kg–1, S.C.) to M3KO mice caused salivation comparable to that in wild-type mice, while no salivation was induced in M1/M3KO mice, indicating that salivation in M3KO mice is caused by an M1-mediated [Ca2+]i increase. In contrast, a lower dose of pilocarpine (1 mg kg–1, S.C.) failed to induce salivation in M3KO mice, but induced abundant salivation in wild-type mice, indicating that M3-mediated salivation has a lower threshold than M1-mediated salivation. In addition, M3KO mice, but not M1KO mice, had difficulty in eating dry food, as shown by frequent drinking during feeding, suggesting that salivation during eating is mediated by M3 and that M1 plays no practical role in it. These results show that the M3 subtype is essential for parasympathetic control of salivation and a reasonable target for the drug treatment and gene therapy of xerostomia, including Sjögren's syndrome.
(Received 16 March 2004;
accepted after revision 7 May 2004;
first published online 14 May 2004)
Corresponding author M. Matsui: Division of Neuronal Network, Department of Basic Medical Sciences, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Email: mmatsui{at}dd.iij4u.or.jp
This article has been cited by other articles:
|
|
 |
|
  X. Liu, K. T. Cheng, B. C. Bandyopadhyay, B. Pani, A. Dietrich, B. C. Paria, W. D. Swaim, D. Beech, E. Yildrim, B. B. Singh, et al. Attenuation of store-operated Ca2+ current impairs salivary gland fluid secretion in TRPC1( / ) mice PNAS, October 30, 2007; 104(44): 17542 - 17547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nishiyama, T. Nakamura, K. Obara, H. Inoue, K. Mishima, N. Matsumoto, M. Matsui, T. Manabe, K. Mikoshiba, and I. Saito Up-Regulated PAR-2-Mediated Salivary Secretion in Mice Deficient in Muscarinic Acetylcholine Receptor Subtypes J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 516 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Dawson, P. C. Fox, and P. M. Smith Sjogrens syndrome--the non-apoptotic model of glandular hypofunction Rheumatology, July 1, 2006; 45(7): 792 - 798. [Full Text] [PDF]
|
|
|
|
 |
|
 G. B. Proctor Muscarinic receptors and salivary secretion J Appl Physiol, April 1, 2006; 100(4): 1103 - 1104. [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Southerland, G. W. Taylor, and S. Offenbacher Diabetes and Periodontal Infection: Making the Connection Clin. Diabetes, October 1, 2005; 23(4): 171 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gautam, S.-J. Han, T. S. Heard, Y. Cui, G. Miller, L. Bloodworth, and J. Wess Cholinergic Stimulation of Amylase Secretion from Pancreatic Acinar Cells Studied with Muscarinic Acetylcholine Receptor Mutant Mice J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 995 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Aihara, Y. Nakamura, M. M. Taketo, M. Matsui, and S. Okabe Cholinergically stimulated gastric acid secretion is mediated by M3 and M5 but not M1 muscarinic acetylcholine receptors in mice Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1199 - G1207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Takeuchi, K. Fujinami, H. Goto, A. Fujita, M. M. Taketo, T. Manabe, M. Matsui, and F. Hata Roles of M2 and M4 Muscarinic Receptors in Regulating Acetylcholine Release From Myenteric Neurons of Mouse Ileum J Neurophysiol, May 1, 2005; 93(5): 2841 - 2848. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
